B · Normal
[Novartis: China is becoming the world's first market for the company's breakthrough therapies] On November 6th, Novartis exhibited its innovative drug under development in the field of immunity, Ianalumab, for the first time at the 9th China International Import Expo, presenting Novartis' relevant research progress in the field of Sjögren's syndrome through the "China First Exhibition". Gao Rong, head of the Novartis Drug Development Department in China, said that the China International Import Expo provides an excellent platform for the company to showcase global innovation results, and China is becoming the world's first market for Novartis' breakthrough therapies.
Comments